Investment
Features
FeesSafety
Academy
More
Pluang+

Compare American Well Corp (AMWL) vs Xylem, Inc. (XYL) Price & Performance

American Well CorpTrade
Xylem, Inc.Trade

Price performance (Past 24H)

Key statistics

American Well Corp vs Xylem, Inc. — how do they compare? American Well Corp trades at $12.56 (market cap $220.94M), while Xylem, Inc. trades at $121.91 (market cap $28.76B). The key difference: Xylem, Inc. is far larger — about 130.2× American Well Corp's market cap, and Xylem, Inc. pays a 1.4% dividend while American Well Corp pays none. Which is the better fit depends on your goals.

AMWLXYL
Market Cap
$220.94M$28.76B
Sector
HealthIndustrials
52-Week High
$13.58$152.95
52-Week Low
$3.78$106.34
Enterprise Value
$27.98M$30.54B
Dividend Yield
1.4%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

American Well Corp

AMWL trades at $12.93, down 4.79% today, with a bullish technical signal from moving averages but overbought RSI readings. The company reported Q2 2026 revenue of $52 million, beating estimates, and continues to narrow losses, targeting cash-flow breakeven by Q4 2026. Recent news includes a key executive joining Amazon's healthcare unit, highlighting strategic relevance.

Outlook hinges on achieving profitability targets amid declining revenues. Opportunities include operational efficiency gains and high-profile partnerships, but risks persist from sustained net losses and competitive pressures. Analyst consensus is cautious with 67% hold ratings.

Xylem, Inc.

XYL trades at $121.59, up 0.33% today, with a bullish technical signal from moving averages and strong quarterly earnings beats. Revenue grew to $9.04B in 2025, with net income margin expanding to 10.59%. Recent acquisitions like Cornell Pump and Roper Pump aim to strengthen its industrial water technology presence, while AI-driven demand for water-treatment equipment supports growth.

The outlook is positive, with a consensus price target of $150.43 implying 24% upside, backed by margin expansion and strategic acquisitions. Risks include execution of integration and potential revenue delays from electric metering projects, as noted in Q2 2026 results. Analyst sentiment is mixed but leans bullish, with 47.5% buy ratings.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About American Well Corp

American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others and its Health System Modules include Acute Behavioral Health, ED Triage, Pediatrics and Telestroke among others.

Read more on AMWL

About Xylem, Inc.

Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $6.2 billion in revenue and $611 million in adjusted operating income in 2021.

Read more on XYL